Thrombomodulin alfa prevents oxaliplatin-induced neuropathic symptoms through activation of thrombin-activatable fibrinolysis inhibitor and protein C without affecting anti-tumor activity-Reference-Cited by-同舟云学术

Thrombomodulin alfa prevents oxaliplatin-induced neuropathic symptoms through activation of thrombin-activatable fibrinolysis inhibitor and protein C without affecting anti-tumor activity

Published:2020-08 Issue: Volume:880 Page:173196
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Minami Tatsuro,Takeda Mineko,Sata Minako,Kato Hiroki,Yano Kazuo,Sakai Takumi,Tsujita Ryuichi,Kawasaki Koh,Ito Akitoshi

Publisher

Elsevier BV

Subject

Pharmacology

Reference39 articles.

1. Thrombin-cofactor interactions: structural insights into regulatory mechanisms;Adams;Arterioscler. Thromb. Vasc. Biol.,2006

2. Effect of synthetic eel calcitonin, elcatonin, on cold and mechanical allodynia induced by oxaliplatin and paclitaxel in rats;Aoki;Eur. J. Pharmacol.,2012

3. Thrombomodulin alfa attenuates thrombin-induced leakage of antithrombin through suppression of endothelial vascular hyperpermeability;Arioka;Thromb. Res.,2017

4. In vivo and in vitro antitumor activity of oxaliplatin in combination with cetuximab in human colorectal tumor cell lines expressing different level of EGFR;Balin-Gauthier;Canc. Chemother. Pharmacol.,2006

5. Potentiation of paclitaxel-induced pain syndrome in mice by angiotensin I converting enzyme inhibition and involvement of kinins;Brusco;Mol. Neurobiol.,2017

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The relationship between gender and pharmacology;Current Research in Pharmacology and Drug Discovery;2024

2. The role of thrombomodulin in modulating ITGB3 expression and its implications for triple‐negative breast cancer progression;Cell Biology International;2023-12-11

3. Effect of a Single Dose of Oxaliplatin on the Induction of Peripheral Neuropathy in a Rat Model: An <i>in Vivo</i> Electrophysiological Study;Biological and Pharmaceutical Bulletin;2023-08-01

4. Evaluation of Sex Differences in Preclinical Pharmacology Research: How Far Is Left to Go?;Pharmaceuticals;2023-05-24

5. Mechanism-based Pharmacological Management of Chemotherapy-induced Neuropathic Pain from Preclinical Studies to Clinical Prospective: Platinum-based Drugs, Taxanes, and Vinca Alkaloids;Current Pharmaceutical Design;2023-02